Precision Antibiotic Dosing for Appendectomy
Recruiting
Phase 1
Interventional Study
Appendicitis (Diagnosis)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 46 (estimated)
- Sponsor
- University of Michigan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This research is studying a drug called cefoxitin already approved by the Food and Drug Administration (FDA) to reduce the risk of infection after surgery to remove an appendix. Researchers are studying a large group of people to continue to learn how best to dose antibiotics. This research will compare the current standard treatment which is a single dose prior to surgery to a new method that inc…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of acute appendicitis and plan to undergo appendectomy at the University of Michigan
Exclusion Criteria:
* Prisoners
* Patients that are pregnant
* Patients with perforation or abscess on CT Scan
Contacts